HIGHLIGHTS
- who: from the We studied , participants within University College London's longitudinal study of FAD between , and , have published the Article: Plasma GFAP in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study, in the Journal: (JOURNAL)
- what: Plasma GFAP concentration in FAD increases presymptomatically, with changes being detected over a decade prior to estimated symptom onset, supporting its further investigation as an accessible biomarker of AD- related astroglial activation.
- how: The authors studied 69 participants within University College London's longitudinal study of FAD between 2010 and 2019 described previously . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.